fatigue
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (3) Inclusion criteria 1. Obtain informed consent; 2. Age= 45 years old, = 75 years old; 3. Ability to follow the test procedure. 4. Have sufficient cognitive ability to sign the informed consent form.
Exclusion criteria
Exclusion criteria: (4) Exclusion criteria 1. Patients who have difficulty taking oral drugs due to underlying diseases and other reasons; 2. Accompanied by serious underlying diseases that affect survival, including uncontrolled clinically significant heart, lung, kidney, digestive, hematological diseases, neuropsychiatric diseases, immune diseases, metabolic diseases, malignant tumors, severe malnutrition, etc.; 3. Allergic constitution, allergic to the products involved in the treatment plan; 4. According to the judgment of the investigator, it is not suitable to use the product involved in the treatment plan. 5. Pregnant or lactating women; 6. Those who are unable to cooperate in mental state, suffer from mental illness, lack of self-awareness, and cannot express themselves clearly; 7. Those who are participating in other clinical trials; According to the investigator's judgment, patients will have complicated enrollment or poor adherence, which will affect the efficacy and safety assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| high-density lipoprotein;fs36;psqi;Triglycerides;Total cholesterol;Fasting blood glucose;waistline;Glycated hemoglobin; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cognitive function; | — |
Countries
china